Recon Technology, Ltd. - Class A Ordinary Shares (RCON)
Live price chart, market sentiment, and community perspectives for Recon Technology, Ltd. (NASDAQ: RCON).
Live price chart, market sentiment, and community perspectives for Recon Technology, Ltd. (NASDAQ: RCON).
On our desk, RCON is a textbook case of severe distress meeting structural dilution. Following their 1-for-200 reverse stock split, the stock immediately tanked by 25% to test multi-dollar lows before minor after-hours bounces. When you couple a collapsing equity price with a newly established $100M at-the-market (ATM) share offering via Pacific Century Securities, the potential dilution for existing shareholders is staggering. Market sentiment across Twitter and StockTwits remains deeply bearish, reflecting widespread lack of confidence in this Beijing oilfield services name as it fights Nasdaq delisting warnings.
In our technical evaluation protocols, trading instruments undergoing massive reverse splits like RCON demand extreme caution regarding wide bid-ask spreads and sudden liquidity vacuums. Traders are attempting to map out risk using the post-split opening session range—especially after the drop to an intraday low of $3.02 and a bounce to $4.80. However, with the looming shadow of the $300M total shelf capacity and the $100M ATM program potentially flooding the market with hundreds of millions of new Class A shares, long-term fundamental support is practically non-existent.
From a quantitative risk management perspective, RCON exhibits classic catastrophic drawdown patterns, trading down over 98% year-to-date with a market cap dwindling near the low millions. The Nasdaq bid-price warning gave them until November 2, 2026, to regain compliance, triggering the aggressive 1-for-200 share consolidation effective August 18, 2026. However, reducing the float from roughly 192.6 million to under 1 million shares has only unleashed extreme intraday volatility without solving the underlying core fundamental deterioration or weak operational earnings.
Explore plasma cleansing, somatic organ swaps, and BCI.